Propranolol Treatment for Infantile Hemangiomas: Short-Term Adverse Effects and Follow-Up to Age Two

Table 5

Multivariate analysis of adverse effects.

Characteristic	B	SE	Wald	p	OR	95% CI
Total AE
≤3 months					1
>3 months	−0.678	0.267	6.442	0.011	0.508	0.301–0.857
Constant	−1.345	0.171	61.684	0	0.261
GI
Constant	−2.098	0.153	188.088	<0.001	0.123
CNS effect
≤3 months					1
>3 months	−1.196	0.485	6.079	0.014	0.303	0.117–0.783
Constant	−2.424	0.253	91.785	<0.001	0.089

Binary logistic regression model with a variable entry criterion of 0.05 and an emission standard of 0.10.